Three-Year Real-World LEQEMBI Data Presented at CTAD 2026
New three-year real-world data from the LEQEMBI LEADER study were presented at CTAD 2026, including findings on amyloid clearance.
New three-year real-world data from the LEQEMBI LEADER study were presented at CTAD 2026, including findings on amyloid clearance.